2nd course of Paxlovid OK for rebounding symptoms, Pfizer says

Pfizer executives said people whose COVID-19 symptoms rebound after taking the antiviral Paxlovid should repeat the treatment, though federal guidelines only recommend one five-day treatment course, Bloomberg reported May 3.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive